Chronic Total Occlusion of the Left Main Coronary Artery in an HIV-Infected Patient

References

• Worm SW, De Wit S, Weber R, et al. Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency Virus. Circulation. 2009;119(6):805–811. doi:10.1161/CIRCULATIONAHA.108.790857
   Web of Science ®Google Scholar
• Wit SD, De Wit S, Sabin CA, et al. Incidence and risk factors for new-onset diabetes in HIV-infected patients: the data collection on adverse events of anti-HIV drugs (D:A:D) study. Diabetes Care. 2008;31(6):1224–1229. doi:10.2337/dc07-2013
   PubMed Web of Science ®Google Scholar
• Seecheran VK, Giddings SL, Seecheran NA. Acute coronary syndromes in patients with HIV. Coron Artery Dis. 2017;28(2):166–172. doi:10.1097/MCA.0000000000000450
   PubMed Web of Science ®Google Scholar
• Vachiat A, McCutcheon K, Tsabedze N, et al. HIV and ischemic heart disease. J Am Coll Cardiol. 2017;69(1):73–82. doi:10.1016/j.jacc.2016.09.979
   PubMed Web of Science ®Google Scholar
• Escaut L, Monsuez JJ, Chironi G, et al. Coronary artery disease in HIV infected patients. Intensive Care Med. 2003;29(6):969–973. doi:10.1007/s00134-003-1740-0
   Web of Science ®Google Scholar
• Mehta NJ, Khan IA. HIV-associated coronary artery disease. Angiology. 2003;54(3):269–275. doi:10.1177/000331970305400302
   PubMed Web of Science ®Google Scholar
• Boccara F, Mary-Krause M, Teiger E, et al. Acute coronary syndrome in human immunodeficiency virus-infected patients: characteristics and 1 year prognosis. Eur Heart J. 2011;32(1):41–50. doi:10.1093/eurheartj/ehq372
   PubMed Web of Science ®Google Scholar
• Valle M, Virtanen K, Hekali P, et al. Survival with total occlusion of the left main coronary artery. Significance of the collateral circulation. Cathet Cardiovasc Diagn. 1979;5(3):269–275. doi:10.1002/ccd.1810050308
   Google Scholar
• Kahveci G, Bozok S, Mungan U. Survival following acute complete occlusion of the left main coronary artery associated with major collateral from the right coronary artery. Cardiovasc Revasc Med. 2009;10(3):213–214. doi:10.1016/j.carrev.2008.12.004
   Google Scholar
• Kanabar K, Mehrotra S, Rajan P. Ostial left main coronary artery chronic total occlusion presenting as chronic stable angina. Indian Heart J. 2018;70(5):745–749. doi:10.1016/j.ihj.2018.04.012
   Google Scholar
• Sasaguri S, Honda Y, Kanou T. Isolated coronary ostial stenosis compared with left main trunk disease. Jpn Circ J. 1991;55(12):1187–1191. doi:10.1253/jcj.55.1187
   Google Scholar
• Sugishita K, Shimizu T, Kinugawa K-I, et al. Chronic total occlusion of the left main coronary artery. Intern Med. 1997;36(7):471–478. doi:10.2169/internalmedicine.36.471
   Web of Science ®Google Scholar
• Burgazli KM, Chasan R, Kavukcu E, et al. Transcatheter aortic valve implantation: our experience and review of the literature. Balkan Med J. 2012;29(2):118–123. doi:10.5152/balkanmedj.2012.004
   Web of Science ®Google Scholar
• Seecheran R, Seecheran V, Persad S, et al. Atypical presentation of critical left main disease in an HIV-infected patient. Int Med Case Rep J. 2018;11:139–143. doi:10.2147/IMCRJ.S164642
   Web of Science ®Google Scholar
• Meier P, Schirmer SH, Lansky AJ, et al. The collateral circulation of the heart. BMC Med. 2013;11(1):143. doi:10.1186/1741-7015-11-143
   PubMed Web of Science ®Google Scholar
• Tayebjee MH, Lip GYH, MacFadyen RJ. Collateralization and the response to obstruction of epicardial coronary arteries. QJM. 2004;97(5):259–272. doi:10.1093/qjmed/hch053
   Web of Science ®Google Scholar
• Gili S, Marra WG, D’Ascenzo F, et al. Comparative safety and efficacy of statins for primary prevention in human immunodeficiency virus-positive patients: a systematic review and meta-analysis. Eur Heart J. 2016;37(48):3600–3609. doi:10.1093/eurheartj/ehv734
   PubMed Web of Science ®Google Scholar
• D’Ascenzo F, Cerrato E, Calcagno A, et al. High prevalence at computed coronary tomography of non-calcified plaques in asymptomatic HIV patients treated with HAART: a meta-analysis. Atherosclerosis. 2015;240(1):197–204. doi:10.1016/j.atherosclerosis.2015.03.019
   PubMed Web of Science ®Google Scholar
• Lo J, Abbara S, Shturman L, et al. Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men. AIDS. 2010;24(2):243–253. doi:10.1097/QAD.0b013e328333ea9e
   PubMed Web of Science ®Google Scholar
• Ramadan R, Boden WE, Kinlay S. Management of left main coronary artery disease. J Am Heart Assoc. 2018;7(7). doi:10.1161/JAHA.117.008151
   Web of Science ®Google Scholar
• Boccara F, Cohen A, Angelantonio E, et al. Coronary artery bypass graft in HIV-infected patients: a multicenter case control study. Curr HIV Res. 2008;6(1):59–64. doi:10.2174/157016208783571900
   PubMed Web of Science ®Google Scholar
• Filsoufi F, Salzberg SP, Harbou KTJ, et al. Excellent outcomes of cardiac surgery in patients infected with HIV in the current era. Clin Infect Dis. 2006;43(4):532–536. doi:10.1086/505977
   Web of Science ®Google Scholar
• Xenogiannis I, Karmpaliotis D, Alaswad K, et al. Left main chronic total occlusion percutaneous coronary intervention: a case series. J Invasive Cardiol. 2019;31:E220–E225.
   Web of Science ®Google Scholar
• Boccara F, Cohen A. HIV and heart disease: what cardiologists should know. Rev Esp Cardiol. 2016;69(12):1126–1130. doi:10.1016/j.recesp.2016.05.037
   Web of Science ®Google Scholar
• Shukla M, Agarwal M, Singh JV, et al. Nonadherence to antiretroviral therapy among people living with HIV/AIDS attending two tertiary care hospitals in district of Northern India. Indian J Community Med. 2016;41(1):55–61. doi:10.4103/0970-0218.170970
   PubMedGoogle Scholar
• Bangsberg DR, Perry S, Charlebois ED, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15(9):1181–1183. doi:10.1097/00002030-200106150-00015
   PubMed Web of Science ®Google Scholar
• Assawasuwannakit P, Braund R, Duffull SB. A model-based meta-analysis of the influence of factors that impact adherence to medications. J Clin Pharm Ther. 2015;40(1):24–31. doi:10.1111/jcpt.12219
   Web of Science ®Google Scholar